| Age group | N (%), n = 187 |
| 16 - 26 | 79 (42.2) |
| 27 - 37 | 56 (29.9) |
| 38 - 48 | 26 (13.9) |
| ≥49 | 26 (13.9) |
| Gender |
|
| Male | 133 (71.1) |
| Female | 54 (28.9) |
| Overall Treatment outcomes (TO) | N (%), n = 233 |
| Treatment completed | 4 (1.7) |
| Cured | 192 (82.4) |
| Loss to follow up | 16 (6.9) |
| Died | 19 (8.2) |
| Treatment Failure | 2 (0.9) |
| TO among underweight patient | N (%), n = 192 |
| Treatment completed | 3 (1.6) |
| Cured | 155 (80.7) |
| Loss to follow up | 15 (7.8) |
| Died | 17 (8.9) |
| Treatment Failure | 2 (1.0) |
| TO among normal, over weight and obese patient | N (%), n = 41 |
| Treatment completed | 1 (2.4) |
| Cured | 37 (90.2) |
| Loss to follow up | 1 (2.4) |
| Died | 2 (4.9) |
| Treatment Failure | 0 (0.0) |